New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 19, 2017 – Par launched an AB-rated generic version of Horizon’s Buphenyl (sodium phenylbutyrate) 500 mg tablets.
Download PDF
Return to publications
